Rate My Professor Imran Ahmad

Ahmad's research centers on mechanisms of treatment-resistance in advanced prostate cancer, employing state-of-the-art in vivo models and patient samples to identify drivers of progression, novel biomarkers, and drug targets. His laboratory investigates the interplay between metabolism, the immune system, and disease progression. He earned his PhD from the University of Glasgow, winning the 2013 Thomas and Margaret Smellie Prize for the best PhD thesis by a medical graduate and the Hunterian Professorship from the Royal College of Surgeons of England. Key awards include the 2022 EAU Best Paper on Fundamental Research, 2017 EAU Best Paper on Fundamental Research, 2018 American Urological Association and BAUS Visiting Scholar Programme, 2017 Chairman’s Award at NHS GG&C, and 2014 ARTP Award. Prominent publications feature 'Sleeping Beauty screen reveals Pparg activation in metastatic prostate cancer' (PNAS, 2016), 'HER2 overcomes PTEN (loss)-induced senescence to cause aggressive prostate cancer' (PNAS, 2011), 'Loss of ARID1A accelerates prostate tumourigenesis with a proliferative collagen-poor phenotype through co-operation with AP1 subunit cFos' (British Journal of Cancer, 2025), and 'Feasibility and safety of radical prostatectomy for oligo-metastatic prostate cancer: the TRoMbone trial' (BJU International, 2022). His work profoundly impacts urological oncology through surgical advancements and fundamental research insights.